Screening for Women

The Women's Health Screenings Worth Knowing — and the Gaps Worth Closing

Women in their 50s are, statistically, the most health-engaged demographic in the UK. They attend GP appointments more consistently than men, they're more likely to act on health information, and they make up the majority of the readership of sites like this one. And yet women in this age group face a specific set of screening blind spots that the NHS invitation system doesn't fully address — partly because the programmes were designed around the most common conditions, and partly because the decade around menopause creates a cascade of health risks that the standard check-up cadence wasn't built to catch.

The starting point is knowing what you're entitled to and making sure you're actually getting it. Cervical screening attendance in England has been falling for over a decade — it hit a 20-year low in 2018 and has recovered only partially since. Breast screening uptake varies significantly by region and socioeconomic group. These are not abstract statistics. They represent people who received invitations, didn't attend, and in some cases were diagnosed later at a more advanced stage than would have been necessary. The single most impactful thing on this page is the reminder to respond to invitations promptly and to self-refer if you think you've been missed.

Women's Health Screenings

Your Complete Guide — NHS, What to Ask For, and What Changes After 50

Women's health needs shift significantly through the 40s, 50s and 60s — particularly around menopause. This guide maps what's available, what's worth asking for, and what most women don't realise they should be monitoring.

Your NHS Entitlements — Free and Automatic

25–64

Cervical screening (smear test)

Every 3 years aged 25–49, every 5 years aged 50–64. Now tests for HPV first — the virus behind almost all cervical cancers. This test prevents cancer, not just detects it. Uptake has been falling. Don't skip it.

50–71

Breast screening (mammogram)

Every 3 years. An X-ray that can find cancers too small to feel. Most women who go find nothing to worry about — but for those where something is found, early detection is the difference that matters. You can self-refer after 71.

50–74

Bowel cancer screening

Every 2 years. A home kit is posted to you — no clinic visit needed. Return a small sample and the lab does the rest. Bowel cancer is just as common in women as men and highly treatable when caught early.

40–74

NHS Health Check

Every 5 years. Checks blood pressure, cholesterol, blood sugar and your risk of heart disease, stroke and diabetes. Don't wait for the letter — ask your GP to book this now if you haven't had one recently.

After Menopause — What Changes and Why It Matters

Before menopause, oestrogen offers significant protection against heart disease and bone loss. That protection disappears almost overnight. A woman's cardiovascular risk rises sharply in the decade after menopause — and can equal a man's within 10 years. Bone density can fall by up to 20% in the first five years after the menopause. These are not slow changes. They need active monitoring.

Ask GP

Bone density scan (DEXA)

A quick, painless scan that measures bone strength. Most women aren't offered this until they've already had a fracture — by which point significant loss has occurred. Ask for it at menopause, especially if you had an early menopause, have a small frame, smoke, or have a family history of osteoporosis.

Ask GP

Full cardiovascular check — beyond standard cholesterol

Ask specifically for ApoB and an inflammation marker (hsCRP) alongside the standard lipid panel. Heart disease is the leading cause of death in women over 60 — but women are less likely to be investigated, less likely to be prescribed preventative medication, and more likely to present with atypical symptoms.

Ask GP

Menopause review and HRT conversation

HRT has been significantly rehabilitated by more recent evidence. For most women under 60 and within 10 years of menopause, the benefits outweigh the risks — for bones, cardiovascular health, cognitive function and quality of life. If your GP hasn't raised this, raise it yourself.

Worth Considering Privately

Full skin check

A head-to-toe check by a dermatologist. Not on any NHS programme. Melanoma caught early is almost always curable.

Hearing test

Hearing loss in your 50s is one of the strongest modifiable risk factors for dementia. Most people wait far too long to address it.

Hormone panel

A broader look at oestrogen, testosterone, thyroid and cortisol — useful context for fatigue, mood changes and weight shifts that GPs often attribute to "just getting older".

Heart scan (CAC score)

Detects early plaque build-up in heart arteries before symptoms appear. Particularly valuable for women with a family history of heart disease or an early menopause.

💡 Women's heart disease is systematically under-investigated. Symptoms are more likely to be atypical — fatigue, jaw pain, nausea — and more likely to be dismissed. If something feels wrong, push for a full cardiovascular workup regardless of your age.

Cervical screening — what's changed and why it matters more now

Cervical screening runs from age 25 to 64, with frequency depending on age and previous results. The shift from cytology to HPV primary testing, which was completed across England by 2019, made the programme significantly more sensitive — it now detects high-risk HPV infection before abnormal cell changes have developed, allowing for earlier intervention. This is genuinely good news, but it comes with a detail worth knowing: a positive HPV result without abnormal cells means you'll be invited back in 12 months for a repeat test, not referred immediately. That's intentional — most HPV infections clear on their own — but it can feel alarming without context.

Two points that repeatedly cause confusion. First, HPV vaccination does not remove the need for screening. The vaccine protects against the highest-risk strains (HPV 16 and 18), but not all oncogenic strains. Vaccinated women still need to attend every cervical screening invitation. Second, women who have never been sexually active are still invited, because the programme is population-wide — but the absolute risk is very low in that group and the decision about whether to attend is reasonably personal. Women outside the 25–64 range who have symptoms or concerns should see their GP rather than waiting; the screening programme doesn't cover those presentations.

Breast screening — understanding the evidence honestly

Breast screening by mammogram is offered every three years to women aged 50 to 71. The evidence supports attendance: screening in this age group reduces breast cancer mortality by around 20% in invited populations, through earlier detection of cancers that are smaller and more treatable. That is a meaningful benefit and the reason the programme exists.

The honest picture also includes the overdiagnosis debate, which is real and worth understanding rather than dismissing. Some cancers detected by mammography — estimates vary from around 1 in 6 to higher in some analyses — would never have caused symptoms or death if left undetected. They are real cancers that nonetheless would not have progressed to harm. The consequence is treatment — surgery, radiotherapy, sometimes chemotherapy — that in retrospect wasn't needed. This doesn't mean screening is net harmful; the current consensus is that it isn't. It means that a positive result should prompt careful conversation about the specific findings rather than an automatic assumption that aggressive treatment is the only option. The NHS Breast Screening Programme's own information leaflet acknowledges the overdiagnosis issue directly — which is the intellectually honest position.

Women who have a family history of breast cancer — particularly first-degree relatives diagnosed before 50, or known BRCA1 or BRCA2 mutations in the family — should discuss enhanced surveillance with their GP rather than relying on the standard three-yearly invitation. This may include earlier mammography, annual screening, or MRI in addition to mammography. The referral threshold for a family history assessment has been lowered in recent years and is more accessible than many people realise.

Bone density — the screening the NHS mostly doesn't offer, but should be on your radar

Osteoporosis is one of the more consequential and undertreated conditions in women over 50, and it is largely invisible without a DEXA scan. Bone loss accelerates sharply in the years around menopause — oestrogen plays a significant protective role in bone metabolism, and its withdrawal at menopause triggers a period of accelerated resorption that can reduce bone density by 10–15% in the five years following the final period. By the time a fracture occurs, the window for easy prevention has often passed.

The NHS does not offer routine DEXA scanning to all postmenopausal women — it's targeted at those with identified risk factors. The FRAX tool (available online) calculates your ten-year fracture risk based on age, weight, family history, smoking, alcohol use, corticosteroid use, and other factors, and can be used to assess whether a referral is warranted. Women who have had a fragility fracture, who have a family history of hip fracture, who have had early menopause (before 45), or who have used corticosteroids for more than three months should specifically ask their GP about DEXA assessment — it is not automatically offered but is available on referral. Private DEXA scanning is widely available for around £80–150 if you'd rather not wait.

Cardiovascular risk — the most underdiscussed area for women in this age group

Cardiovascular disease is the leading cause of death in women over 50 in the UK, yet it is consistently underestimated — by women themselves and, research suggests, sometimes by clinicians. Heart attack presentation in women more frequently involves atypical symptoms: fatigue, nausea, jaw or shoulder pain, breathlessness — rather than the classic crushing chest pain associated with male heart attack presentation. This contributes to later presentation, later diagnosis, and worse outcomes.

The NHS Health Check covers basic cardiovascular risk — blood pressure, cholesterol, blood glucose, BMI — and is the most relevant routine screen for this. But the standard cholesterol measurement captured in a Health Check (total cholesterol) misses important nuance. Lipoprotein(a), or Lp(a), is a genetically determined cardiovascular risk factor that is elevated in roughly one in five people and is not included in routine lipid panels. It is a significant independent predictor of heart attack and stroke, it doesn't respond to statins the way LDL does, and it can only be identified by a specific blood test. If you have a family history of early heart disease and normal standard cholesterol, asking about Lp(a) is a reasonable and evidence-supported step.

Blood pressure measurement at home, using a validated upper-arm cuff, is worth considering alongside the five-yearly Health Check. Hypertension is common, largely asymptomatic, and significantly modifiable — and blood pressure can vary enough between clinic and home readings that home monitoring gives a truer picture of your actual baseline.

Menopause, HRT, and the monitoring conversation

This sits adjacent to screening but is worth naming clearly. Women on hormone replacement therapy should be having regular reviews with their GP — at least annually — to assess ongoing suitability, discuss any changes in symptoms, and ensure blood pressure is being monitored. HRT does not require routine blood tests in most cases, but the review conversation matters, particularly as guidance on duration of use has evolved significantly in recent years. Women who were told to stop HRT after five years on the basis of older guidance may find that a current review produces a different recommendation.

Women approaching or in perimenopause who haven't yet discussed HRT, or who were told it wasn't suitable for them, may find it worth revisiting that conversation in light of updated NICE guidance (2023) which significantly expanded the evidence base for its use and safety in most women.

'Cervical screening attendance has been falling for a decade. Bone loss in the five years after menopause can reach 15%. Cardiovascular disease is the leading killer of women over 50 — and it frequently presents without the symptoms we were taught to expect. The invitation system won't catch all of this. Knowing what to ask for is part of the job.'

Building your own screening picture

The invitation system covers what it covers. The gap between that and a genuinely complete picture of your health at 50-plus requires some active construction. Keep a record of what you've had done and when. Know your blood pressure number, your cholesterol figure, and your HbA1c if it's ever been tested. If you have a family history of any condition — cancer, heart disease, osteoporosis, autoimmune disease — make sure your GP has it documented and has considered whether it changes your screening schedule.

The most useful single conversation is one where you go to your GP not with symptoms but with questions: what is my actual cardiovascular risk score? Should I be thinking about a DEXA scan? Is there anything in my family history that changes what I should be monitoring? A GP who is used to reactive consultations may not automatically shift into that mode — but most will, if you arrive with those questions formed.